Tag: Laprophan
Business Headlines Morocco

Laprophan Invests MAD 374 Million in Sterile Injectables Plant as It Prepares Stock-Market Listing

North Africa PostComments Off on Laprophan Invests MAD 374 Million in Sterile Injectables Plant as It Prepares Stock-Market Listing

Moroccan drugmaker Laprophan is investing MAD 374 million in a sterile injectables unit at Aïn El Aouda, near Rabat, Le360 reports, as the group prepares a stock-market listing worth up to MAD 2.22 billion. The plant, built to EU-GMP standards, belongs to the subsidiary Amanys Pharma and is due to open in 2027. The Aïn […]
Business Headlines Morocco

Laprophan gets green light for Casablanca IPO valued at up to $228 mln

North Africa PostComments Off on Laprophan gets green light for Casablanca IPO valued at up to $228 mln

Moroccan pharmaceutical group Laprophan has received AMMC approval for its IPO on the Casablanca Stock Exchange, targeting up to 2.22 billion dirhams (about $228 million). The offering, the third major listing planned in 2026 after T2S Group Holding and Jet Energy, will float 37.64% of the capital, according to a prospectus published by capital market […]
Business Europe Headlines Morocco

Morocco’s Laprophan Makes History with First European Acquisition, Taking Control of Swiss Rivopharm

North Africa PostComments Off on Morocco’s Laprophan Makes History with First European Acquisition, Taking Control of Swiss Rivopharm

Morocco’s Laprophan pharmaceutical group has finalized the acquisition of a majority stake in Rivopharm, a Swiss company specializing in specialty medicines, complex pharmaceutical formulations and high-value regulatory expertise, reported medias24. The deal, completed on June 17, marks Laprophan’s first European acquisition and what its president describes as a historic milestone for Moroccan pharmaceutical industry on […]